Introduction
Candida albicans was incidentally found as a contaminant in endometrial cell cultures obtained at hysterectomy and in endometrial cell cultures obtained from endometrial aspiration. It was thought that although contamination of the endometrium could have occurred whilst performing an endometrial aspirate, this was much less likely in a hysterectomy specimen. The patients were then retreated with either a repeat dose of clotrimazole or oral fluconazole in a single dose of 500 mg and 150 mg respectively. The STD screen, candidal specimen collection and endometrial aspiration were then repeated one week later.
The candidal specimens obtained from the high vagina, endocervix, rectum and from vaginal aspiration were innoculated onto culture plates of Sabouraud's agar with chloramphenicol (SC). Growth was graded from +/-to + + +. Of the 20 ml of saline suspension aspirated from the vagina, 0 2 ml was spread over the surface of SC plates. A 1/10 dilution of the suspension was also made, Of the 20 patients who completed the study three admitted to having sexual intercourse without using a condom between the first and second visit, and seven between the Discussion This study suggests that the endometrium is not commonly a resevoir for candida species in patients with recurrent vaginal candidiasis. The one positive candidal isolate was C krusei found at a higher count in the vagina than in the endometrium, the failure to remove candida from the vagina raises the high possibility of endometrial contamination, via the transcervical route. The double lumen endometrial sampling method used in this study has been shown to minimise the risk of transcervical contamination if quantitative culture is performed.7 C krusei is known to adhere to vaginal cells in much lesser numbers than C albicans thus explaining its lesser virulence in causing vulvo-vaginitis. 5 It is possible that pretreatment of the vagina with clotrimazole may affect candida within the endometrium, but it is known that serum levels of clotrimazole after topical vaginal treatment are negligible.9 Between 3%-10% of vaginally administered drug is absorbed. Application of a 500 mg pessary results in a peak plasma level of <0 01 ,ug/ml suggesting rapid metabolism. This plasma concentration is considered non-fungicidal, mitigating against a systemic effect of vaginally administered clotrimazole. Direct transcervical spread of clotrimazole from vagina to uterus would seem unlikely in view of the physiological barrier of the cervical mucus plug and the flow of cervical secretions downwards from the cervix.
The results of this study lead us to conclude that in cases of recurrent vaginal candidiasis, an endometrial resevoir of candidal species is an unlikely cause. This study was supported by a grant from Pfizer Ltd.
